MedPath
FDA Approval

Dysport

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
September 28, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

IPSEN BIOPHARM LTD

Ipsen Biopharmaceuticals, Inc.

365113203

Products2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Dysport

Product Details

NDC Product Code
15054-0500
Application Number
BLA125274
Marketing Category
BLA (C73585)
Route of Administration
INTRAMUSCULAR
Effective Date
September 28, 2023
albumin humanInactive
Code: ZIF514RVZRClass: IACT
Code: E211KPY694Class: ACTIBQuantity: 500 U in 1 1
lactose monohydrateInactive
Code: EWQ57Q8I5XClass: IACT

Dysport

Product Details

NDC Product Code
15054-0530
Application Number
BLA125274
Marketing Category
BLA (C73585)
Route of Administration
INTRAMUSCULAR
Effective Date
September 28, 2023
Code: E211KPY694Class: ACTIBQuantity: 300 U in 1 1
albumin humanInactive
Code: ZIF514RVZRClass: IACT
lactose monohydrateInactive
Code: EWQ57Q8I5XClass: IACT
© Copyright 2025. All Rights Reserved by MedPath